Answers are grounded in this paper and cite their sources.
The objective was to characterize real-world outcomes of drug-drug interactions (DDIs) between antiretrovirals (ARVs) and other drugs, including over-the-counter medications (OTC), and treatment outcomes in clinical practice.
No takes yet. Share an insight, caveat, or question.
Ambrosioni et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: